235 related articles for article (PubMed ID: 19211364)
1. [Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies].
Malouf G; Baudin E; Soria JC; Schlumberger M
Bull Cancer; 2009 Jan; 96(1):95-101. PubMed ID: 19211364
[TBL] [Abstract][Full Text] [Related]
2. Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Oncol; 2008 Jan; 20(1):19-24. PubMed ID: 18043252
[TBL] [Abstract][Full Text] [Related]
3. New molecular targeted therapies in thyroid cancer.
Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of thyroid cancer.
Sherman SI
Biochem Pharmacol; 2010 Sep; 80(5):592-601. PubMed ID: 20471374
[TBL] [Abstract][Full Text] [Related]
5. Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer.
Ho AL; Sherman E
Clin Adv Hematol Oncol; 2011 Jan; 9(1):32-41. PubMed ID: 21326144
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy for thyroid cancer: An updated review of investigational agents.
Deshpande HA; Gettinger SN; Sosa JA
Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid cancer: molecular biology and novel molecular therapies.
Cakir M; Grossman AB
Neuroendocrinology; 2009; 90(4):323-48. PubMed ID: 19468197
[TBL] [Abstract][Full Text] [Related]
8. Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.
Lalami Y; Awada A
Curr Opin Oncol; 2011 May; 23(3):235-40. PubMed ID: 21330922
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy: a new hope for thyroid carcinomas.
Perri F; Pezzullo L; Chiofalo MG; Lastoria S; Di Gennaro F; Scarpati GD; Caponigro F
Crit Rev Oncol Hematol; 2015 Apr; 94(1):55-63. PubMed ID: 25465739
[TBL] [Abstract][Full Text] [Related]
10. Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications.
Keefe SM; Cohen MA; Brose MS
Clin Cancer Res; 2010 Feb; 16(3):778-83. PubMed ID: 20103668
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy in radioiodine refractory thyroid cancer.
Pacini F; Brilli L; Marchisotta S
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):520-5. PubMed ID: 19910905
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies for advanced thyroid cancer.
Puxeddu E; Romagnoli S; Dottorini ME
Curr Opin Oncol; 2011 Jan; 23(1):13-21. PubMed ID: 21045687
[TBL] [Abstract][Full Text] [Related]
13. EVOLUTION OF TARGETED THERAPIES FOR THYROID CARCINOMA.
Sherman SI
Trans Am Clin Climatol Assoc; 2019; 130():255-265. PubMed ID: 31516190
[TBL] [Abstract][Full Text] [Related]
14. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
[TBL] [Abstract][Full Text] [Related]
15. Target therapies for radioiodine refractory advanced thyroid tumors.
Schlumberger M
J Endocrinol Invest; 2012; 35(6 Suppl):40-4. PubMed ID: 23014073
[TBL] [Abstract][Full Text] [Related]
16. Treatment directed to signalling molecules in patients with advanced differentiated thyroid cancer.
Sáez JM
Anticancer Agents Med Chem; 2013 Mar; 13(3):483-95. PubMed ID: 22583421
[TBL] [Abstract][Full Text] [Related]
17. [Targeted therapy in thyroid cancer: Towards a treatment card].
Lkhoyaali S; Benhmida S; Ait Elhaj M; Layachi M; Bensouda Y; Errihani H
Pathol Biol (Paris); 2015 Feb; 63(1):1-6. PubMed ID: 25555494
[TBL] [Abstract][Full Text] [Related]
18. Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions.
Dadu R; Cabanillas ME
Minerva Endocrinol; 2012 Dec; 37(4):335-56. PubMed ID: 23235190
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeted therapies for patients with refractory thyroid cancer.
Chougnet C; Brassard M; Leboulleux S; Baudin E; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):448-55. PubMed ID: 20554167
[TBL] [Abstract][Full Text] [Related]
20. [New drugs and targeted therapeutic agents in ovarian cancer].
de La Motte Rouge T; Petrella MC; Michels J; Even C; Balleyguier C; Duclos J; Mazeron R; Morice P; Pautier P; Lhommé C
Bull Cancer; 2009 Dec; 96(12):1215-24. PubMed ID: 19919916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
